{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:10Z","timestamp":1791655390112,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.it.2014.01.003","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T10:30:32Z","timestamp":1393669832000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Cellular immune controls over Epstein\u2013Barr virus infection: new lessons from the clinic and the laboratory"],"prefix":"10.1016","volume":"35","author":[{"given":"Alan B.","family":"Rickinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaimainthan","family":"Palendira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fcnz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Hislop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2014.01.003_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2014.01.003_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: a role for natural killer cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.it.2014.01.003_bib0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/428910","article-title":"Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children","volume":"191","author":"Moormann","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2014.01.003_bib0020","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood.V98.13.3739","article-title":"Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load","volume":"98","author":"Silins","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0025","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1172\/JCI25078","article-title":"Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis","volume":"115","author":"Clute","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1084\/jem.20112401","article-title":"Primary Epstein-Barr virus infection does not erode preexisting CD8(+) T cell memory in humans","volume":"209","author":"Odumade","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-3083.2007.01980.x","article-title":"The expression of human natural killer cell receptors in early life","volume":"66","author":"Sundstrom","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.01777-06","article-title":"The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing","volume":"81","author":"Pappworth","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0045","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4049\/jimmunol.1102462","article-title":"EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail","volume":"190","author":"Griffin","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0050","doi-asserted-by":"crossref","first-page":"13224","DOI":"10.1073\/pnas.0503594102","article-title":"Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors","volume":"102","author":"Stewart","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0055","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.0407522101","article-title":"Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs","volume":"101","author":"Ferlazzo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0060","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.ppat.0040027","article-title":"Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma","volume":"4","author":"Strowig","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2014.01.003_bib0065","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","article-title":"A distinct subpopulation of human NK cells restricts B cell transformation by EBV","volume":"191","author":"Lunemann","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0070","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","article-title":"Innate immune control of EBV-infected B cells by invariant natural killer T cells","volume":"122","author":"Chung","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0075","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.4049\/jimmunol.1003615","article-title":"CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling","volume":"186","author":"Allan","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.it.2014.01.003_bib0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0090","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"Blake","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0095","doi-asserted-by":"crossref","first-page":"e1000699","DOI":"10.1371\/journal.ppat.1000699","article-title":"T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display","volume":"5","author":"Mackay","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2014.01.003_bib0100","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1073\/pnas.0801968105","article-title":"Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition","volume":"105","author":"Tellam","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0105","doi-asserted-by":"crossref","first-page":"e1003112","DOI":"10.1371\/journal.ppat.1003112","article-title":"Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1","volume":"8","author":"Tellam","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2014.01.003_bib0110","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01369-08","article-title":"mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1","volume":"83","author":"Apcher","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0115","doi-asserted-by":"crossref","first-page":"e1001151","DOI":"10.1371\/journal.ppat.1001151","article-title":"Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation","volume":"6","author":"Apcher","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2014.01.003_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.20041542","article-title":"CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells","volume":"201","author":"Pudney","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0125","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","article-title":"CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response","volume":"191","author":"Abbott","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.semcancer.2008.10.008","article-title":"Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products","volume":"18","author":"Ressing","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.it.2014.01.003_bib0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.micinf.2009.12.001","article-title":"Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity","volume":"12","author":"Rowe","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.it.2014.01.003_bib0140","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"Adhikary","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1100590","article-title":"Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition","volume":"187","author":"Long","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0150","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20121437","article-title":"MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response","volume":"210","author":"Long","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0155","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.84.2.570","article-title":"Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection","volume":"84","author":"Henle","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jmv.1890390311","article-title":"Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins","volume":"39","author":"Hille","year":"1993","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/491740","article-title":"A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis","volume":"192","author":"Balfour","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2014.01.003_bib0170","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.4049\/jimmunol.177.6.3746","article-title":"A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells","volume":"177","author":"Taylor","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0175","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1073\/pnas.0909448107","article-title":"Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display","volume":"107","author":"Leung","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-62703-218-6_35","article-title":"Antigen processing for MHC presentation via macroautophagy","volume":"960","author":"Gannage","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.it.2014.01.003_bib0185","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/428097","article-title":"Long-term shedding of infectious epstein-barr virus after infectious mononucleosis","volume":"191","author":"Fafi-Kremer","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2014.01.003_bib0190","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bjh.12422","article-title":"Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases","volume":"162","author":"Parvaneh","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.it.2014.01.003_bib0195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jaci.2013.07.020","article-title":"Natural killer cell deficiency","volume":"132","author":"Orange","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0200","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V88.8.3022.bloodjournal8883022","article-title":"Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections","volume":"88","author":"de Vries","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2249.1996.tb08295.x","article-title":"Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)","volume":"103","author":"Jawahar","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0210","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0215","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/503269","article-title":"A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8","volume":"78","author":"Eidenschenk","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.it.2014.01.003_bib0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI61014","article-title":"Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency","volume":"122","author":"Gineau","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0225","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1172\/JCI60224","article-title":"MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans","volume":"122","author":"Hughes","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0230","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0235","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0240","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics and immunity","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM199501053320103","article-title":"Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS","volume":"332","author":"McClain","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0250","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/561548","article-title":"AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases","author":"Purgina","year":"2011","journal-title":"Patholog. Res. Int."},{"key":"10.1016\/j.it.2014.01.003_bib0255","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1182\/blood-2011-10-385377","article-title":"Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency","volume":"119","author":"Shaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0260","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM198512193132502","article-title":"Replication of Epstein-Barr virus within the epithelial cells of oral \u201chairy\u201d leukoplakia, an AIDS-associated lesion","volume":"313","author":"Greenspan","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0265","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0270","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach","volume":"96","author":"Stepensky","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.it.2014.01.003_bib0275","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/leu.2011.371","article-title":"Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases","volume":"26","author":"Linka","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2014.01.003_bib0280","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2013.01.042","article-title":"Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation","volume":"131","author":"Moshous","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0285","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2011-09-378158","article-title":"The phenotype of human STK4 deficiency","volume":"119","author":"Abdollahpour","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0290","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood-2011-09-378364","article-title":"MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival","volume":"119","author":"Nehme","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0300","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.it.2014.01.003_bib0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jaci.2011.11.013","article-title":"CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia","volume":"129","author":"van Montfrans","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3324\/haematol.2012.068791","article-title":"Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27","volume":"98","author":"Salzer","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.it.2014.01.003_bib0320","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ijc.2910350404","article-title":"Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma","volume":"35","author":"Rowe","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.it.2014.01.003_bib0325","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1684\/mrh.2011.0286","article-title":"Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency","volume":"24","author":"Li","year":"2011","journal-title":"Magnes. Res."},{"key":"10.1016\/j.it.2014.01.003_bib0330","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2014.01.003_bib0335","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.it.2014.01.003_bib0340","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM197402142900704","article-title":"Fatal infectious mononucleosis in a family","volume":"290","author":"Bar","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0345","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.it.2014.01.003_bib0350","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJM197507102930202","article-title":"Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children","volume":"293","author":"Provisor","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0360","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","article-title":"SLAM family receptors and SAP adaptors in immunity","volume":"29","author":"Cannons","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0365","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.it.2014.01.003_bib0370","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2010-03-275909","article-title":"X-linked lymphoproliferative syndromes: brothers or distant cousins?","volume":"116","author":"Filipovich","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0375","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0380","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood-2011-01-328849","article-title":"Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG","volume":"118","author":"Rigaud","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0385","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0390","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood-2009-09-238832","article-title":"Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets","volume":"116","author":"Hislop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0395","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency","volume":"119","author":"Snow","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2014.01.003_bib0400","doi-asserted-by":"crossref","first-page":"e1001187","DOI":"10.1371\/journal.pbio.1001187","article-title":"Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP","volume":"9","author":"Palendira","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2014.01.003_bib0405","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1084\/jem.20112391","article-title":"Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus","volume":"209","author":"Palendira","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0410","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1128\/JVI.05742-11","article-title":"Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans","volume":"85","author":"Orlova","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0415","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00852-13","article-title":"CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques","volume":"87","author":"Leskowitz","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0420","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1126\/science.276.5321.2030","article-title":"An animal model for acute and persistent Epstein-Barr virus infection","volume":"276","author":"Moghaddam","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.it.2014.01.003_bib0425","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coviro.2013.03.003","article-title":"Nonhuman primate models for Epstein-Barr virus infection","volume":"3","author":"Wang","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2014.01.003_bib0430","doi-asserted-by":"crossref","first-page":"e1003095","DOI":"10.1371\/journal.ppat.1003095","article-title":"An Epstein-Barr virus encoded inhibitor of colony stimulating factor-1 signaling is an important determinant for acute and persistent EBV infection","volume":"8","author":"Ohashi","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2014.01.003_bib0435","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/eji.201343815","article-title":"Infectious diseases in humanized mice","volume":"43","author":"Leung","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.it.2014.01.003_bib0445","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20081720","article-title":"Priming of protective T cell responses against virus-induced tumors in mice with human immune system components","volume":"206","author":"Strowig","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0450","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1086\/644644","article-title":"T cell mediated control of Epstein-Barr virus infection in humanized mice","volume":"200","author":"Yajima","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.it.2014.01.003_bib0455","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2012.03585.x","article-title":"Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice","volume":"136","author":"Jaiswal","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.it.2014.01.003_bib0460","doi-asserted-by":"crossref","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0465","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.4049\/jimmunol.1103660","article-title":"Development of mature and functional human myeloid subsets in hematopoietic stem cell engrafted NOD\/SCID\/IL2rgammaKO mice","volume":"188","author":"Tanaka","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2014.01.003_bib0470","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","article-title":"Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence","volume":"116","author":"Strowig","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0475","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1182\/blood-2012-12-473413","article-title":"CD141+ dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice","volume":"121","author":"Meixlsperger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0480","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.it.2014.01.003_bib0485","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bjorkstrom","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.it.2014.01.003_bib0490","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.it.2014.01.003_bib0495","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.0915054107","article-title":"HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma","volume":"107","author":"Hjalgrim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2014.01.003_bib0500","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2012.43.5784","article-title":"Improving T-cell therapy for epstein-barr virus lymphoproliferative disorders","volume":"31","author":"Bollard","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.it.2014.01.003_bib0505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1358\/dnp.2010.23.4.1439500","article-title":"Immunotherapy for Epstein-Barr virus-associated malignancies","volume":"23","author":"Long","year":"2010","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.it.2014.01.003_bib0510","doi-asserted-by":"crossref","first-page":"107fs107","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2014.01.003_bib0515","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490614000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490614000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T22:36:37Z","timestamp":1597530997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490614000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1471490614000167"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2014.01.003","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular immune controls over Epstein\u2013Barr virus infection: new lessons from the clinic and the laboratory","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2014.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}